Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

An Illinois appellate judge upheld a pervious trial victory that cleared and central Illinois cardiologist Amit Dande, MD, and Prairie Cardiovascular Consults LLP of alleged misdiagnosis of the severity of a patient's heart condition that led to his death prior to a schedule percutaneous coronary intervention (PCI).

Illinois cardiologist not held responsible for patient's death while waiting for angiogram

A judge upheld a previous trial victory that cleared Prairie Cardiovascular Consults of alleged mishandling of a patient and not fully understanding the severity of the heart condition prior to their death.

Thumbnail

Implementing a same-day PCI discharge pathway boils down to correct patient selection

Safety is key to which individuals are selected for SDD, and there can be benefits to both patients and health systems as this becomes the predominant model of care in elective PCI.

A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare

Anticoagulants after TAVR: 5-year survival data favor DOACs over VKAs

However, that one finding does not tell the whole story. Researchers also found that DOACs may increase a TAVR patient's risk of a disabling stroke.

Surender Malhotra, MD, an interventional cardiologist with Fairview Park Hospital in Dublin, Georgia, is back on the job after losing his right arm in a near-fatal accident.

Georgia cardiologist treating heart patients again after losing arm in accident

A veteran interventional cardiologist lost his right arm in an accident, but did not let that stop him from returning to his patients. 

doctor looking at CLTI patient's leg

FDA grants bioresorbable scaffold system its breakthrough device designation to treat infrapopliteal lesions

The new drug-eluting device was designed to provide both stability and flexibility to patients presenting with below-the-knee lesions.  

An FDA panel will discuss its recommendations related to Abbott's TriClip G4 transcatheter edge-to-edge repair (TEER) system for tricuspid regurgitation.

FDA advisory panel votes in favor of Abbott’s TriClip device for tricuspid regurgitation

After hours of discussion, the panel determined that the benefits of using the TriClip G4 TEER system to treat TR outweigh any potential risks. 

doctor examines patient data on their tablet

New American College of Cardiology registry focuses on data from outpatient ambulatory surgical centers

The ACC launched its latest registry knowing that volumes at these outpatient facilities are expected to rise in the years ahead. 

An FDA panel will discuss its recommendations related to Abbott's TriClip G4 transcatheter edge-to-edge repair (TEER) system for tricuspid regurgitation.

FDA panel to consider Abbott’s TriClip device for tricuspid regurgitation

The panel's decision will be based on data from the TRILUMINATE study, which was ultimately positive for Abbott, but did lead to certain questions about patient outcomes.